With the campaign, Highlights REAL, they are spotlighting the everyday experiences of advanced prostate cancer patients and ...
Spire Southampton Hospital has continued its investment in robotic surgery with the addition of the Aquablation therapy ...
World’s first robotic Prostatic Artery Embolization (PAE) for Benign Prostatic Hyperplasia (BPH) and robotic Y-90 ...
Where previous research showed that PSMA therapy for prostate cancer can prolong the lives of patients who have exhausted all ...
Supporting a loved one with prostate cancer? Learn how to provide care, manage side effects, and navigate emotional and ...
The study published by Bastiaan M Privé and colleagues in The Lancet Oncology represents, to our knowledge, the first randomised phase 2 trial evaluating lutetium-177–PSMA-617 (177Lu-PSMA-617) in ...
New FDA approvals and emerging trial data drive two pivotal 2026 NCCN guideline updates: lutetium-177 PSMA-617 for ...
Lirafugratinib, an oral FGFR2 inhibitor, receives FDA Priority Review for advanced cholangiocarcinoma with FGFR2 rearrangements or fusions.